Sponsor or institution

Clinical trials and research at Zhejiang University

• 84Clinical trials
• 1Country

Newest trials

All recruiting trials (84)

• Preferences of physicians and patients for cell therapies in advanced solid tumors

  This study tests how doctors and patients weigh the benefits, risks, and burdens of CAR-T, TIL, TCR-T, and NK cell therapies in advanced solid cancers.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT07813000

• Neoadjuvant therapy with encorafenib plus cetuximab N01 and mFOLFOX6 in locally advanced BRAF V600E-mutant colorectal cancer

  This trial tests a targeted, pre-surgery treatment to see if it improves the chance of long-term control in adults with locally advanced BRAF V600E-mutant colorectal cancer.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang · NCT07789210

• Rectal indomethacin after prostate surgery to see if it lowers CRBD

  This study tests whether a 50 mg rectal indomethacin suppository given after laparoscopic radical prostatectomy can reduce catheter-related bladder discomfort in adults.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT07607990

• Neoadjuvant fulzerasib plus cetuximab N01 for KRAS G12C–mutated locally advanced colorectal cancer

  This trial will try a chemo-free combination of fulzerasib and cetuximab N01 before surgery in adults with KRAS G12C–mutated locally advanced colorectal cancer, including some with resectable metastases.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang · NCT07581912

• Electrical acupoint stimulation plus three anti-nausea drugs to prevent post-op nausea in high-risk women

  This trial will test whether adding wearable electrical acupoint stimulation to three anti-nausea drugs reduces postoperative nausea and vomiting in high-risk adult women having elective laparoscopic surgery.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT07480785

• SYNCAR-100 for adults with relapsed or refractory B‑cell acute lymphoblastic leukemia

  This study will try SYNCAR-100, a circRNA-based injectable therapy, in adults with CD19-positive relapsed or refractory B‑cell acute lymphoblastic leukemia to see if it is safe and helps control the disease.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT07429461

• Video-guided right-sided double-lumen tube for one-lung ventilation in thoracoscopic surgery

  This trial tests whether a video-guided right-sided double-lumen tube helps place and use the tube during thoracoscopic surgery requiring one-lung ventilation, compared with a conventional tube.

  Recruiting at 2 sites Zhejiang University · Hangzhou, Zhejiang and 2 other locations · NCT07362797

• Laryngopharyngeal injuries after breathing tube placement during general anesthesia

  This project sees how often and why people who had a breathing tube during general anesthesia developed hoarseness or other throat problems after non-ear–nose–throat surgery.

  Recruiting Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT07359586

• High-flow nasal oxygen to prevent low oxygen during sedated endoscopy in people with high-risk sleep apnea

  This will test whether using high‑flow nasal oxygen instead of a regular nasal cannula prevents low oxygen levels during propofol‑sedated gastroscopy or colonoscopy in adults with high‑risk obstructive sleep apnea (STOP‑Bang ≥5).

  Recruiting at 3 sites Zhejiang University · Hangzhou, Zhejiang and 2 other locations · NCT07307560

• Diaphragm function after an interscalene block with liposomal bupivacaine

  This study tests whether liposomal bupivacaine used with an interscalene block affects diaphragmatic function in adults having upper limb surgery.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT07263295

• Cetuximab beta plus fruquintinib, with or without immunotherapy, for first-line treatment of RAS/BRAF wild‑type unresectable metastatic colorectal cancer

  This trial tests whether combining cetuximab beta and fruquintinib, with or without immune checkpoint inhibitors, can control cancer as a chemotherapy‑free first‑line option for patients with RAS/BRAF wild‑type unresectable metastatic colorectal cancer.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang · NCT07257653

• IL-5 CAR-T therapy for refractory or relapsed eosinophilic leukemia

  We will test whether IL-5 CAR-T cells can help adults with CD125-positive refractory or relapsed eosinophilic leukemia.

  Recruiting Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT07257640

• CD19 CAR-T for adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia

  This study will test CD19 CAR‑T cell therapy in adults newly diagnosed with Philadelphia chromosome–positive acute lymphoblastic leukemia to see if it can induce remission.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang · NCT07252336

• Using high-flow nasal cannulas to prevent oxygen drops during sedated GI endoscopy in critically ill patients

  This trial will test whether high-flow nasal cannulas during sedated gastrointestinal endoscopy can prevent low oxygen levels in critically ill (ASA 3–4) adults.

  Recruiting at 3 sites Zhejiang University · Shenzhen, Guangdong and 2 other locations · NCT07252102

• KSV01 injection for adults with relapsed or refractory B‑cell acute lymphoblastic leukemia

  This will test a new KSV01 CAR therapy injection to see if it is safe and helps adults with relapsed or refractory B‑cell acute lymphoblastic leukemia.

  Recruiting Phase 1 Zhejiang University · Hangzhou · NCT07246707

• HRS-4642 plus nimotuzumab and chemotherapy for borderline resectable pancreatic cancer with KRAS G12D

  This Phase II trial will test whether adding HRS-4642 and nimotuzumab to gemcitabine and albumin-bound paclitaxel helps adults with borderline resectable pancreatic cancer that has a KRAS G12D mutation.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT07240766

• COMBO airway plus high-flow nasal oxygen during sedated gastrointestinal endoscopy for morbidly obese adults

  This test will try combining the COMBO Endoscopy oropharyngeal airway with high-flow nasal oxygen to see if it reduces low-oxygen episodes during sedated gastrointestinal endoscopy in adults with BMI 35 or higher.

  Recruiting at 5 sites Zhejiang University · Beijing, Beijing Municipality and 4 other locations · NCT07175155

• Donor-derived CD117 CAR-T cells for relapsed or refractory acute myeloid leukemia

  This trial will try donor-derived CD117 CAR-T cells to treat patients with CD117-positive relapsed or refractory acute myeloid leukemia.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT07144020

• Autologous neoantigen T-cell therapy for advanced liver cancer

  This treatment tries a personalized neoantigen-specific T-cell therapy for people with advanced hepatocellular carcinoma who have not responded to two or more systemic treatments.

  Recruiting Phase 1/2 Zhejiang University · Hangzhou, Zhejiang · NCT07123545

• Risk prediction for gastric retention during sedated gastroscopy

  This study will test a simple grading system and prediction model to see if clinicians can identify which adults are likely to have significant stomach contents before sedated gastroscopy.

  Recruiting at 2 sites Zhejiang University · Hangzhou, Zhejiang and 2 other locations · NCT07104214

• China Colorectal Cancer Screening 1 (C-Cost1)

  This project will test whether one-time colonoscopy, annual FIT, or annual FIT plus a blood cfDNA methylation test best detects colorectal cancer and advanced adenomas in average-risk adults aged 45–74 in China.

  Recruiting at 7 sites Zhejiang University · Guandong and 6 other locations · NCT07090291

• Removing the spleen with open debridement for necrotizing pancreatitis and left-sided portal hypertension

  This trial will test whether removing the spleen during open debridement helps adults with acute necrotizing pancreatitis and left-sided (sinistral) portal hypertension recover faster and with fewer complications than debridement alone.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT07080697

• Supraglottic oxygen delivery through an endotracheal tube for ERCP under deep sedation

  This tests whether delivering oxygen just above the vocal cords through an endotracheal tube can prevent low oxygen levels in adults having ERCP with deep sedation.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang · NCT07051980

• Scalp nerve block with liposomal versus standard bupivacaine for post-craniotomy pain relief

  This trial will test whether adding liposomal bupivacaine to scalp nerve blocks gives longer, better pain relief than standard bupivacaine for adults after elective craniotomy.

  Recruiting Phase 4 Zhejiang University · Hangzhou, Zhejiang · NCT07049094

• CG-102-12C for GPC3-positive advanced liver cancer

  This will test whether a single infusion of CG-102-12C can help people aged 18–75 with GPC3‑positive advanced hepatocellular carcinoma who did not respond to standard systemic treatments.

  Recruiting Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT07039201

• Hepatic-artery NKG2D CAR-NK followed by IV NKG2D CAR-T for advanced solid tumors with liver metastases

  This treatment will try a two-step approach—hepatic artery infusion of NKG2D CAR-NK cells followed by intravenous NKG2D CAR-T cells—for people with advanced solid tumors that have spread to the liver and did not respond to standard treatments.

  Recruiting Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT07021534

• COMBO oropharyngeal airway during sedated ERCP

  This test will see if the COMBO Endoscopy Oropharyngeal Airway reduces episodes of low oxygen (hypoxia) in adults undergoing ERCP with propofol sedation.

  Recruiting at 2 sites Phase 2 Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT07012772

• Anti-mesothelin CAR-T therapy for advanced mesothelin-positive solid tumors

  This trial will test whether Anti-Mesothelin CAR-T cell therapy given after a short chemotherapy preparation helps people with advanced mesothelin-positive solid tumors.

  Recruiting Zhejiang University · Hangzhou · NCT07010523

• Personalized mRNA therapy for advanced liver cancer

  This study is testing a new personalized mRNA therapy combined with other treatments to see if it can help people with advanced liver cancer feel better.

  Recruiting Phase 1/2 Zhejiang University · Hangzhou, Zhejiang · NCT06995105

• Personalized mRNA therapy for advanced liver cancer

  This study is testing a personalized mRNA therapy combined with standard chemotherapy to see if it can help people with advanced liver cancer feel better.

  Recruiting Phase 1/2 Zhejiang University · Hangzhou, Zhejiang · NCT06956716

• CAR-T therapy targeting CDH17 for advanced solid tumors

  This study is testing a new CAR-T cell therapy aimed at treating advanced solid tumors that have a specific marker called CDH17 in patients who have run out of other treatment options.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06937567

• UCAR T-cell therapy for patients with systemic lupus erythematosus

  This study is testing a new type of CAR T-cell therapy to see if it can help people with tough cases of systemic lupus erythematosus feel better.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06920433

• MT027 treatment for advanced abdominal tumors

  This study is testing a new CAR-T cell therapy called MT027 to see if it can safely help people with advanced abdominal tumors.

  Recruiting Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06912152

• Boosting vaccination uptake with points-reward digital platform in China

  A digital platform-based, point-reward program is being tested to see if it can help people get non-NIP vaccines like HPV, flu, and pneumonia vaccines.

  Recruiting Zhejiang University · Quzhou, Zhejiang · NCT06890559

• Treatment of advanced cancers using CEA-targeted CAR-T cells

  This study is testing a new type of CAR-T cell treatment for people with advanced cancers that have a specific marker, to see if it is safe and how well it works for those who haven't had success with other treatments.

  Recruiting Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06821048

• HLA mismatched stem cell transplantation for hematologic diseases

  This study is testing a new stem cell transplant approach for patients with blood cancers who can't find matching donors to see if it can improve their chances of recovery.

  Recruiting Phase 1 Zhejiang University · Hangzhou · NCT06809712

• HLA mismatched stem cell transplantation for hematologic diseases

  This study is testing if using stem cells from donors who aren't a perfect match can help people with blood cancers get the treatment they need when they can't find a suitable donor.

  Recruiting Phase 1 Zhejiang University · Hangzhou, China · NCT06809699

• Using a new airway device to reduce low oxygen levels during endoscopy in obese patients

  This study tests if a new airway device can help obese patients keep their oxygen levels up during gastrointestinal endoscopy compared to using a regular nasal cannula.

  Recruiting at 3 sites Zhejiang University · Hangzhou, Zhejiang and 2 other locations · NCT06796764

• Using donor-derived CAR-T cells to treat relapsed B-cell leukemia

  This study is testing a new type of CAR-T cell therapy made from donor cells to see if it can help people with relapsed B-cell leukemia feel better.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06793241

• CD7 CAR-T cell treatment for blood and immune system diseases

  This study is testing a new CAR-T cell treatment combined with stem cell transplants to see if it can help people with certain blood and immune system diseases feel better.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06787560

• CAR-T Cell Therapy for Lupus Nephritis

  This study is testing a new CAR-T cell therapy to see if it can help people with tough-to-treat lupus nephritis feel better.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06785519

• HRS-4642 with nimotuzumab plus gemcitabine and nab-paclitaxel as first-line treatment for advanced pancreatic cancer with KRAS G12D

  This trial will try HRS-4642 together with nimotuzumab and standard gemcitabine/nab‑paclitaxel chemotherapy as first‑line treatment for people with metastatic pancreatic cancer whose tumors carry the KRAS G12D mutation.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT06770452

• IBI343 plus gemcitabine and albumin‑bound paclitaxel for advanced pancreatic cancer

  This trial will test whether adding IBI343 to gemcitabine and albumin‑bound paclitaxel helps people with CLDN18.2‑positive advanced pancreatic adenocarcinoma.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT06770439

• Treatment for Schimke Immuno-osseous Dysplasia using CAR-T and Kidney Transplantation

  This study is testing a new treatment that combines special immune cells and kidney transplants to see if it can help people with Schimke immuno-osseous dysplasia who have severe kidney disease.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06769191

• Exploring CD33 CAR-T Cell Therapy for Acute Myeloid Leukemia

  This study is testing a new CAR-T cell therapy for people with relapsed or hard-to-treat acute myeloid leukemia to see if it can help them feel better.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06762132

• Treatment of relapsed B-cell Non-Hodgkin lymphoma with CAR-T cells

  This study is testing a new type of CAR-T cell treatment to see if it can help people with relapsed B-cell Non-Hodgkin lymphoma feel better and achieve remission.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06716164

• Using CAR-T cells to treat moderate to severe lupus

  This study is testing if a new type of CAR-T cell therapy can help people with moderate to severe lupus feel better and manage their symptoms.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06711146

• Autologous CD19 CAR-T (CNCT19) for advanced liver cancer

  This trial will try autologous CD19 CAR-T cells (CNCT19) as a treatment for adults with advanced hepatocellular carcinoma who have progressed after at least two lines of systemic therapy.

  Recruiting Phase 1 Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT06676982

• Evaluating OL-101 Injection for Patients with Relapsed or Refractory Multiple Myeloma

  This study is testing a new treatment called OL-101 to see if it can help adults with multiple myeloma that has come back or hasn’t responded to other treatments.

  Recruiting Phase 1 Zhejiang University · Beijing, Beijing Municipality and 2 other locations · NCT06644118

• Using CD5 CAR-T Cells to treat relapsed T-Acute Lymphoblastic Leukemia

  This study is testing a new type of CAR-T cell therapy to see if it can help people with relapsed T-Acute Lymphoblastic Leukemia feel better and improve their chances of recovery.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06633354

• Using CD5 CAR-T Cells to treat relapsed T-lymphoma

  This study is testing a new type of CAR-T cell therapy to see if it can help people with relapsed T-lymphoma feel better and improve their health.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06633341

• CD7 CAR-T therapy for severe aplastic anemia before stem cell transplant

  This study is testing a new CAR-T cell therapy for people with severe aplastic anemia to see if it can help them before they receive a stem cell transplant.

  Recruiting Early Phase 1 Zhejiang University · Hanzhou, Zhejiang · NCT06633328

• Combining Bortezomib with PD-1 antibody and chemotherapy for advanced pancreatic cancer

  This study is testing a new combination of treatments, including Bortezomib, a PD-1 antibody, and chemotherapy, to see if it can help people with advanced pancreatic cancer.

  Recruiting Phase 1/2 Zhejiang University · Hangzhou, Zhejiang · NCT06572813

• Comparing two treatments for elderly patients with acute myeloid leukemia after initial remission

  This study is testing whether a new drug called venetoclax or a stem cell transplant works better for older patients with acute myeloid leukemia who are in remission but at risk of relapse.

  Recruiting Phase 4 Zhejiang University · Hangzhou, Zhejiang · NCT06571825

• Treatment using CAR-T cells targeting GPC3 for advanced liver cancer

  This study is testing a new type of immune cell treatment for people with advanced liver cancer to see if it is safe and helps fight the disease.

  Recruiting at 2 sites Phase 1 Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT06461624

• Using islet organoids to treat diabetes after pancreatic surgery

  This study is testing whether transplanting patients' own islet cells, grown in the lab, can help people with diabetes after they've had pancreatic surgery.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT06415643

• Evaluating robotic surgery for liver tumor removal

  This study is testing if using robotic surgery to remove liver tumors is safer and more effective than traditional surgery methods for patients with liver tumors.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT06353672

• CD19-BAFF CAR-T cell therapy for relapsed B-cell leukemia and lymphoma

  This study is testing a new CAR-T cell therapy for people with relapsed B-cell leukemia and lymphoma to see if it is safe and effective.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06346912

• CD19-BAFF CAR-T cell therapy for autoimmune diseases

  This study is testing a new CAR-T cell therapy for people with tough autoimmune diseases who haven't found relief from standard treatments to see if it can help them feel better.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06279923

• Multi-omics approach for early detection of colorectal cancer

  This study is testing a new way to spot colorectal cancer early by looking at blood samples from people with cancer and healthy individuals to see if certain markers can help predict the disease.

  Recruiting at 6 sites Zhejiang University · Hangzhou, Zhejiang and 5 other locations · NCT06220617

• Blocking blood flow during pancreatic tumor removal

  This study is testing a new way to remove certain pancreatic tumors while reducing bleeding and protecting healthy tissue in patients with benign or borderline tumors.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT06164769

• Evaluating LY-M001 Injection for Gaucher Disease Type I in Adults

  This study is testing a new injection called LY-M001 to see if it can safely help adults with Gaucher Disease Type I feel better.

  Recruiting Zhejiang University · Hanzhou, Zhejiang · NCT06162338

• Using engineered CAR-T cells to treat relapsed diffuse large B-cell lymphoma

  This study is testing a new type of CAR-T cell treatment to see if it can help adults with relapsed diffuse large B-cell lymphoma who haven't responded to other therapies.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06120166

• Evaluating YOLT-201 for treating heart issues caused by transthyretin amyloidosis

  This study is testing a new drug called YOLT-201 to see if it is safe and can help people with heart problems caused by transthyretin amyloidosis.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06082050

• Examining the link between donor telomere length and outcomes in acute leukemia patients after stem cell transplantation

  This study is trying to see if the length of telomeres in blood from stem cell donors can affect how well patients with acute leukemia do after their transplant.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT06076226

• Placing a temporary biliary drainage stent during pediatric liver transplant to prevent bile-duct narrowing

  This study will try placing a temporary external biliary drainage stent during liver transplant in children up to 6 years old to see if it reduces bile-duct narrowing and related complications.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT06048445

• Comparing two surgical methods for colon cancer treatment

  This study is testing whether a new type of colon cancer surgery called Laparoscopic Ileocecal-Sparing Right Hemicolectomy can lead to better long-term results than the traditional surgery for patients with specific types of colon cancer.

  Recruiting at 26 sites Zhejiang University · Bengbu, Anhui and 28 other locations · NCT05923255

• Multi-domain lifestyle intervention for older adults at risk of cognitive decline in China

  This study is testing a lifestyle program that includes exercise, healthy eating, brain training, and managing health risks to see if it can help older adults in China avoid memory problems and dementia.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT05886114

• Neoadjuvant treatment for advanced oral cancer using Tislelizumab and chemotherapy

  This study is testing if a new combination of Tislelizumab and chemotherapy can help people with advanced oral cancer before their surgery.

  Recruiting Phase 2 Zhejiang University · Hangzhou · NCT05862168

• Evaluating Serplulimab with Chemotherapy for Lung Cancer Treatment

  This study is testing if adding Serplulimab to chemotherapy can help people with advanced lung cancer turn their tumors into ones that can be surgically removed and live longer without the cancer coming back.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang · NCT05837052

• CD7 CAR-T therapy followed by allogeneic stem cell transplant for relapsed/refractory CD7-positive blood cancers

  This will test whether CD7-directed CAR-T cells given before an allogeneic stem cell transplant are safe for adults with relapsed or refractory CD7-positive acute leukemias.

  Recruiting Phase 1/2 Zhejiang University · Hangzhou, Zhejiang · NCT05827835

• Comparing sequential S-1 therapy after surgery for advanced gastric cancer

  This study is testing if a specific treatment plan using S-1 therapy after surgery can help people with advanced stomach cancer recover better.

  Recruiting Phase 3 Zhejiang University · Hanzhou, Zhejiang · NCT05813015

• Neoadjuvant treatment for locally advanced rectal cancer using Serplulimab, CAPEOX, and Celecoxib

  This study is testing a new treatment combining an immune therapy and chemotherapy to see if it can help people with locally advanced rectal cancer before surgery.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang · NCT05731726

• Comparing two chemotherapy methods for advanced gastric cancer

  This study is testing a new way of giving chemotherapy for advanced stomach cancer to see if it works better than the usual method.

  Recruiting Phase 3 Zhejiang University · Hangzhou, Zhejiang · NCT05593458

• CD70-targeted CAR-T therapy for advanced solid tumors

  This study is testing a new type of CAR-T therapy that targets CD70 to see if it can safely help people with advanced solid tumors.

  Recruiting Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT05518253

• Exploring biomarkers for early detection of pancreatic tumors

  This study is trying to find early warning signs in blood, urine, and other samples from patients with a specific type of pancreatic tumor to see if they can help predict when it might turn cancerous.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT05433935

• Evaluating a new CAR-T cell treatment for advanced liver cancer

  This study is testing a new CAR-T cell treatment for people with advanced liver cancer who can't have surgery to see if it helps shrink tumors and is safe to use.

  Recruiting at 2 sites Phase 1 Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT05155189

• CD70 CAR T-cell therapy for blood cancers

  This study is testing a new CAR T-cell therapy for blood cancers to see if it is safe and effective for patients with certain types of leukemia and lymphoma.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT04662294

• CD19 CAR-T therapy for B-cell non-Hodgkin's lymphoma

  This study is testing a new CAR-T cell therapy for people with B-cell non-Hodgkin's lymphoma who don't want to have standard chemotherapy, to see how safe and effective it is.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang · NCT04661020

• APRIL CAR-T cell therapy for relapsed multiple myeloma patients

  This study is testing a new CAR-T cell therapy for patients with relapsed multiple myeloma to see if it is safe and effective for those who haven't responded well to other treatments.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT04657861

• CD20/CD22 targeted CAR T-cell therapy for blood cancers

  This study is testing a new CAR T-cell therapy that targets specific proteins on blood cancer cells to see if it can help patients whose cancer hasn't responded to other treatments.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT04283006

• Injection of CTA101 UCAR-T cells for patients with relapsed or refractory CD19+ B-line blood cancers

  This study is testing if injections of a new type of immune cell therapy can help patients with certain types of blood cancers that have come back or didn’t respond to other treatments.

  Recruiting Early Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT04227015

• National Colorectal Cancer Cohort for screening and patient outcomes

  This study is trying to find out what increases the risk of colorectal cancer and how to better identify and manage patients who are at high risk.

  Recruiting at 5 sites Zhejiang University · Hangzhou, Zhejiang and 4 other locations · NCT04074538

• A large cohort study on prenatal and early life factors affecting children's health in China

  This study looks at how things like pregnancy and early feeding habits affect the health and growth of children in China.

  Recruiting Zhejiang University · Hangzhou, Zhejiang · NCT03217656

Quick answers

How many clinical trials run by Zhejiang University are recruiting right now?

84, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 22, Phase 2: 13, Phase 1: 12, Phase 1/2: 5. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →